Last update 23 May 2025

Mesenchymal Progenitor Cell Exosomes Nebulizer(Cellular Biomedicine)

Overview

Basic Info

Drug Type
Exosomes
Synonyms
haMPC-Exos(Cellular Biomedicine), MPCs-derived exosomes(Cellular Biomedicine)
Target-
Action-
Mechanism-
Therapeutic Areas
Infectious DiseasesRespiratory Diseases
Active Indication-
Inactive Indication
Carbapenem Resistant Bacterial InfectionInfectious Lung Disorder
Originator Organization
AbelZeta Pharma, Inc.AbelZeta Pharma, Inc.
Active Organization-
Inactive Organization
Shanghai Cellular Biopharmaceutical Group Ltd.Shanghai Cellular Biopharmaceutical Group Ltd.
License Organization-
Drug Highest PhaseSuspendedPhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with Mesenchymal Progenitor Cell Exosomes Nebulizer(Cellular Biomedicine)
NCT04544215
/ SuspendedPhase 1/2IIT
A Clinical Study of Allogeneic Human Adipose-derived Mesenchymal Progenitor Cell Exosomes (haMPC-Exos) Nebulizer for the Treatment of Carbapenem-resistant Gram-negative Bacilli-induced Pulmonary Infection
100 Clinical Results associated with Mesenchymal Progenitor Cell Exosomes Nebulizer(Cellular Biomedicine)
Login to view more data
100 Translational Medicine associated with Mesenchymal Progenitor Cell Exosomes Nebulizer(Cellular Biomedicine)
Login to view more data
100 Patents (Medical) associated with Mesenchymal Progenitor Cell Exosomes Nebulizer(Cellular Biomedicine)
Login to view more data
100 Deals associated with Mesenchymal Progenitor Cell Exosomes Nebulizer(Cellular Biomedicine)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Carbapenem Resistant Bacterial InfectionPhase 2
China
Shanghai Cellular Biopharmaceutical Group Ltd.Shanghai Cellular Biopharmaceutical Group Ltd.
01 Jul 2020
Infectious Lung DisorderPhase 2
China
Shanghai Cellular Biopharmaceutical Group Ltd.Shanghai Cellular Biopharmaceutical Group Ltd.
01 Jul 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free